Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace

Biologics


Exyte and Univercells Technologies Combine Аorces for Rapid Deployment of Vaccine Production Plants in the Wake of the COVID-19 Pandemic

   by White Matter Communications    148
  • Exyte offers the new ExyCellR modular technology for fast-track construction of biologicals production facilities compliant with the current good manufacturing practice (cGMP).
  • Univercells Technologies delivers the integrated NevoLine™ biomanufacturing platform, including scale-X™ bioreactors, for low footprint and economic large-scale production of viral products.
  • The combined offer enables users to rapidly deploy prefabricated GMP vaccine manufacturing facilities in response to new disease outbreaks.

19 Marketplaces for the Life Sciences Industry

   by Andrii Buvailo    23154
19 Marketplaces for the Life Sciences Industry

(Last updated: 12.05.2020)

Online marketplaces are websites with a “many-to-many” business logic. They can host multiple suppliers trading with multiple buyers via different e-commerce tools available as a part of a website functionality.

Why are online marketplaces great?

Online marketplaces can provide a substantial added value to its users. For example, buyers can quickly compare and select better offerings without the need to research multiple websites and surf online for price comparisons or product specifications. Additionally, marketplaces bring more transparency, trust, and standardization to the whole process of sourcing.

3rd Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress

   by BiopharmaTrend    494
3rd Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress

This Congress will explore the novel technologies and manufacturing strategies accelerating the efficient production of next-generation biologics.

With 30+ presentations over two days, this meeting focuses on key challenges within the field, evaluating innovative solutions such as continuous bioprocessing, SUTs, data integrity, PAT and the implementation of industry 4.0, all of which aim to increase the efficiency and yield of therapeutic production whilst maintaining high-quality standards. Once again, this meeting will also feature a track dedicated to the manufacturing of cell and gene therapies, exploring both the regulatory and manufacturing challenges of these complex products.